<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="85607">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01820650</url>
  </required_header>
  <id_info>
    <org_study_id>CCP 12-001</org_study_id>
    <nct_id>NCT01820650</nct_id>
  </id_info>
  <brief_title>A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System</brief_title>
  <official_title>A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ConforMIS, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ConforMIS, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to observe the long term clinical outcomes of patient-specific knee
      arthroplasty in patients with osteoarthritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      If the patient has previously received a standard total knee replacement in their
      contralateral knee,    the primary endpoint questionnaire and some secondary endpoint
      questionnaires will be completed regarding BOTH their iTotal® CR knee and their standard
      total knee for all time points where questionnaires are required by the protocol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>2011 Knee Society Score</measure>
    <time_frame>1 Year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Osteoarthritis of the Knee</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iTotal G2 CR Knee Replacement System</intervention_name>
    <description>Total Knee replacement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with osteoarthritis of the knee
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical condition included in the approved Indications For Use for the iTotal® CR

          -  Osteoarthritis, as confirmed by the investigator's assessment of disease status at
             screening visit that warrants a TKR procedure.  Disease status is assessed by
             Clinical and Radiographic assessment.

          -  Willingness to participate in the clinical study, to give informed consent and to
             attend all follow-up visits

          -  &gt; 18 years of age

        Exclusion Criteria:

          -  Simultaneous bilateral procedure required

          -  BMI &gt; 40

          -  Active malignancy (defined as a history of any invasive malignancy - except
             non-melanoma skin cancer), unless patient has been treated with curative intent and
             there have been no clinical signs or symptoms of the malignancy for at least 5 years

          -  Poorly Controlled diabetes

          -  Neuromuscular conditions which prevent patient from participating in study activities

          -  Active local or systemic infection

          -  Immunocompromised

          -  Fibromyalgia or other general body pain related condition

          -  Rheumatoid arthritis or other forms of inflammatory joint disease

          -  Loss of bone or musculature, osteonecrosis, neuromuscular or vascular compromise in
             the area of the joint to be operated to an extent that the procedure is unjustified

          -  Diagnosed with or receiving treatment for Osteoporosis

          -  Other physical disability affecting the hips, spine, or contralateral knee.

          -  Severe instability due to advanced loss of osteochondral structure

          -  Prior arthroplasty of the affected knee, including High Tibial Osteotomy (HTO)

          -  Compromised PCL or collateral ligament

          -  Severe fixed valgus or varus deformity of  &gt;15º

          -  Extensor lag &gt; 15 º

          -  Fixed flexion contracture ≥ 15 º

          -  Unwilling or unable to comply with study requirements

          -  Participation in another clinical study which would confound results

          -  Allergy to any of the implant materials
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Quartulli</last_name>
    <role>Study Director</role>
    <affiliation>ConforMIS, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Terry Clyburn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>JFK Medical Center</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Kosik</last_name>
      <phone>561-548-1414</phone>
      <email>Jamie.Kosik@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Gregory Martin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Instatute of Henderson</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <zip>89052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Johnston</last_name>
      <phone>702-565-6565</phone>
      <phone_ext>312</phone_ext>
      <email>cJohnston@oihnv.com</email>
    </contact>
    <investigator>
      <last_name>Robert Tait, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tennessee Orthopaedic Alliance</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Vanhooser, PA</last_name>
      <phone>615-329-6600</phone>
      <email>vanhooserkj@toa.com</email>
    </contact>
    <investigator>
      <last_name>William Kurtz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joint Replacement Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Clyburn, MD</last_name>
      <phone>713-357-4752</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mansfield Orthopaedics</name>
      <address>
        <city>Morrisville</city>
        <state>Vermont</state>
        <zip>05661</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leah Moris, MS, PA-C</last_name>
      <phone>802-888-8405</phone>
      <email>lemorse@chsi.org</email>
    </contact>
    <investigator>
      <last_name>Bryan Huber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 13, 2014</lastchanged_date>
  <firstreceived_date>March 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteoarthritis</keyword>
  <keyword>knee replacement</keyword>
  <keyword>patient-specific</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
